Home Newsfeeds Mizuho Maintains Buy on SoFi Technologies, Lowers Price Target to $7

Mizuho Maintains Buy on SoFi Technologies, Lowers Price Target to $7

Mizuho analyst Dan Dolev maintains SoFi Technologies (NASDAQ:SOFI) with a Buy and lowers the price target from $9 to $7.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Mizuho analyst Dan Dolev maintains SoFi Technologies (NASDAQ:SOFI) with a Buy and lowers the price target from $9 to $7.

News

Why Nasdaq-100 Leveraged ETF TQQQ Hit A New 52-Week High Today

By Henry Khederian

July 12, 11:03 AM

ProShares UltraPro QQQ (NASDAQ: TQQQ) shares are trading higher by 3.82% to $42.02 Wednesday morning.

QQQ

Movers
News

Why Generac Stock Is Rising Today

By Ryan Gustafson

June 27, 2:15 PM

Generac Holdings Inc. (NYSE: GNRC) shares are trading higher after the company reportedly said it is seeing increased demand for backup generators in Texas.

GNRC

SciSparc’s CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder

By Vuk Zdinjak

February 27, 12:16 PM

SciSparc Ltd. (NASDAQ: SPRC) has signed an agreement with Israel's manufacturer and distributor of cannabis-based products, Tikun Olam Cannbit Pharmaceuticals Ltd., Israel (TASE:TKUN), to supply CBD-rich oil from Cannbit strains by, to be u

SPRC

Safe Bulkers Divests 2006-Built Kamsarmax Vessel For ~$16M

By Shivani Kumaresan

September 26, 11:31 AM

Safe Bulkers Inc (NYSE: SB) has agreed to sell MV Pedhoulas Trader, a 2006 Japanese-built, Kamsarmax class, dry-bulk vessel, for a net sale price of $15.84 million. The sale carries a forward delivery date lies within December 2022.

Mizuho Maintains Buy on SoFi Technologies, Lowers Price Target to $7

Related Posts

Why Nasdaq-100 Leveraged ETF TQQQ Hit A New 52-Week High Today

Why Generac Stock Is Rising Today

SciSparc’s CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder

Safe Bulkers Divests 2006-Built Kamsarmax Vessel For ~$16M